Opioids & Corporate

Inadequate treatment of pain and abuse of prescription pain medications are both serious public health problems that are increasingly at odds in our society. Corporations that make prescription pain medications have a responsibility to address both problems. For many years, Purdue Pharma has committed substantial resources to combat opioid abuse by partnering with healthcare professionals, patients, caregivers, communities, law enforcement, and government agencies.

For the health of patients who suffer from pain, it’s important to remember that prescription opioids can play an important role in helping to relieve pain. Too often, however, these medications are diverted, misused, and abused.

Purdue is dedicated to being part of the solution to reduce the abuse of prescription opioid medications. Purdue has supported many initiatives to combat opioid abuse, such as educational programs for healthcare professionals and law enforcement, and prescription monitoring programs (PMPs). In addition, Purdue has led the development of opioids with abuse-deterrent properties.

Responsible Use of Opioids

Purdue, as a leader in pain medicine, has provided educational resources to encourage the responsible use of opioids among healthcare professionals, patients, and the general public.

ER/LA Opioid Analgesics REMS

The U.S. Food and Drug Administration (FDA) has mandated that extended-release and long-acting (ER/LA) opioid analgesics have a Risk Evaluation and Mitigation Strategy (REMS) to help ensure that the benefits of the drug outweigh its risks. See how Purdue supports REMS for ER/LA opioid analgesics.

Opioids With Abuse-Deterrent Properties

Purdue was the first company to introduce opioid pain medications with abuse-deterrent properties and labeling claims through development of novel formulations and abuse-deterrence studies.

Combating Opioid Abuse

Purdue works with many partners to help curb diversion, misuse, and abuse of prescription opioids while making sure these medicines remain available for appropriate medical use.

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.